| 000 | 01065cam a2200337 4500 | ||
|---|---|---|---|
| 008 | 040712s2004 sz eng | ||
| 020 | _a9241592370 | ||
| 035 | _a(Sirsi) i9241592370 | ||
| 060 | _aWC 503.1 2004WO-2 | ||
| 110 | 2 |
_aWorld Health Organization. _bDept. of Essential Health Technologies. |
|
| 710 | 2 | _aUNAIDS. | |
| 710 | 2 | _a | |
| 245 | 1 | 0 |
_aHIV assays : _boperational characteristics (Phase 1). _nReport 15, _pAntigen/antibody ELISAs. |
| 260 |
_aGeneva : _bWorld Health Organization, _c2004. |
||
| 300 | _a57 p. | ||
| 856 | _uhttps://apps.who.int/iris/ | ||
| 500 | _a. | ||
| 546 | _aeng. | ||
| 550 | _aWHODOC. | ||
| 561 | _aWHO monograph. | ||
| 650 | 0 | 2 | _aEnzyme-linked immunosorbent assay. |
| 650 | 0 | 2 |
_aHIV antigens _xanalysis. |
| 650 | 0 | 2 |
_aHIV infections _xdiagnosis. |
| 650 | 0 | 2 |
_aAIDS serodiagnosis _xmethods. |
| 650 | 0 | 2 |
_aHIV seropositivity _xdiagnosis. |
| 650 | 0 | 2 |
_aReagent kits, Diagnostic _xutilization |
| 650 | 0 | 2 | _aClinical trials, Phase I. |
| 690 | _aAIDS and its Control. | ||
| 596 | _a4 | ||
| 942 |
_2NLM _cMONOGRAPH |
||
| 999 |
_c28741 _d28741 |
||